Upcoming Meetings: Rep. Shays blood safety hearing
This article was originally published in The Gray Sheet
Executive Summary
Rep. Shays blood safety hearing: House Government Reform/Human Resources Subcommittee Chair Christopher Shays (R-Conn.) schedules second oversight hearing Nov. 2 to address "efforts by the government and blood products industry to protect the nation's blood supply from emerging infectious agents." Topics to be addressed include "the role of blood industries in ensuring the safety of blood and blood products, industry quality standards, and the application of new manufacturing technologies that may improve product safety." Witnesses include representatives from the Centers for Disease Control and Prevention, the National Institutes of Health, the American Red Cross, Bayer Corp. and Baxter Healthcare...